PEOPLE - SpineMark makes appointment:
This article was originally published in Clinica
Executive Summary
SpineMark, a San Diego, California-based company focused on creating a network of centres of excellence in spine-related research and treatment, has appointed Alan Iftiniuk as COO and Alan Donald as president of the firm's clinical research management division. Mr Iftiniuk has more than 25 years' experience in hospital management and healthcare consulting, and will work to ensure a combination of innovation and fiscal success. Mr Donald has advised companies in the diagnostics, medical devices, biologics and pharma sectors for over 25 years. He will be responsible for setting up clinical trial programmes between medical device companies and physicians.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.